All Companies
Ticker ACLX
This stock is no longer actively trading
You reached the page — here's exactly what ACLX is, and why it's out of scope for now.
What this ticker is
ACLX
Arcellx, Inc.
NASDAQ
Healthcare
Biotechnology
United States
Mkt cap $6.7B
Arcellx, Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering immunotherapeutic solutions for patients battling cancer and other intractable diseases. A cornerstone of their pipeline is CART-ddBCMA, an advanced ddCAR product candidate currently undergoing a Phase 1 clinical trial. This investigational treatment targets individuals suffe…
Why we can't analyze it yet
This ticker is delisted or inactive, so its financial data is frozen or incomplete and we don't produce a live analysis for it — the figures would be stale. Here's what the ticker is and why it's out of scope.
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
delisted